|
|
(106 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
| __NOTOC__ | | __NOTOC__ |
| *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| + | |
| | | |
| *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
− | *'''[[Reviews on covid19 disease]]'''
| |
| | | |
| + | *'''[[Reviews on covid19 disease]]''' |
| *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
− | {{tp|p=32360205|t=ä. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?|pdf=|usr=}}
| |
| | | |
| | | |
− | ----
| + | |
| + | *'''[[Respiration mgmt]]''' |
| + | |
| + | *'''[[Diagnosis (Laboratory)]]''' |
| + | |
| + | |
| + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| + | |
| + | *'''[[Diagnosis (other modalities)]]''' |
| + | |
| + | |
| | | |
| | | |
| *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| + | |
| | | |
| *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
− |
| |
| *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| + | |
| + | |
| | | |
| *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
Zeile 23: |
Zeile 35: |
| *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| | | |
| + | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | |
| | | |
− | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
| |
| | | |
− | ----
| + | *'''[[Pathobiology]]''' |
| + | |
| + | |
| + | *'''[[Disease Models]]''' |
| + | |
| + | |
| + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | |
| | | |
Zeile 37: |
Zeile 55: |
| | | |
| *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
− | {{tp|p=32307254|t=ä. Invasive fungal diseases during COVID-19: We should be prepared |pdf=|usr=}}
| |
− | {{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}}
| |
− | {{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}}
| |
| | | |
− |
| |
− | *'''[[ARDS]]'''
| |
| | | |
| *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| | | |
− | *'''[[Hematology]]'''
| |
| | | |
− | *'''[[Microvascular]]'''
| |
| | | |
− | *'''[[Heart]]'''
| |
| | | |
| | | |
− | *'''[[Neurology, ophthalmology, orl]]''' | + | *'''[[Hematology]]''' |
− | {{tp|p=32320008|t=ä. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection |pdf=|usr=}}
| + | |
− | {{tp|p=32275288|t=ä. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China |pdf=|usr=}}
| + | |
− | {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}}
| + | |
| | | |
− | *'''[[Dermatology]]'''
| |
− | {{tp|p=32352022|t=2020. Urticarial exanthem as early diagnostic clue for COVID-19 infection |pdf=|usr=}}
| |
− | {{tp|p=32346588|t=ä. Dermatologic findings in two patients with COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32313826|t=ä. Morbilliform exanthem associated with COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32363225|t=ä. Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings |pdf=|usr=}}
| |
| | | |
| | | |
| + | *'''[[Heart]]''' |
| | | |
| | | |
− | *'''[[Gastroenterology, hepatology]]'''
| |
− | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| |
− | {{tp|p=32249184|t=ä. Can COVID-19 present unusual GI symptoms?|pdf=|usr=}}
| |
| | | |
− | *'''[[Kidney, urology]]''' | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | |
− | ----
| |
| | | |
| | | |
− | *'''[[Pathobiology]]''' | + | *'''[[Dermatology]]''' |
| | | |
− | *'''[[Disease Models]]'''
| |
| | | |
− | *'''[[Similar diseases and pathomechanisms]]'''
| |
− | {{tp|p=32370951|t=ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic |pdf=|usr=}}
| |
| | | |
− | ----
| + | *'''[[Gastroenterology, hepatology]]''' |
| | | |
| + | *'''[[Kidney, urology]]''' |
| | | |
− | *'''[[Diagnosis (Laboratory)]]''' | + | *'''[[The morbid survivor]]''' |
| | | |
| + | *'''[[Risk and special populations]]''' |
| | | |
| | | |
− | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| | | |
− | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Case reports]]''' |
− | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[Respiration mgmt]]'''
| |
− | {{tp|p=32340627|t=2020. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic |pdf=|usr=}}
| |
| | | |
| | | |
− | *'''[[Risk and special populations]]'''}
| |
| | | |
| | | |
− | *'''[[The morbid survivor]]'''
| |
− | {{tp|p=32219356|t=ä. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
− | {{tp|p=32369030|t=2020. Considerations for Postacute Rehabilitation for Survivors of COVID-19 |pdf=|usr=}}
| |
| | | |
| + | *'''[[Case series]]''' |
| | | |
− | *'''[[Case reports]]'''
| |
− | {{tp|p=32168162|t=ä. A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital |pdf=|usr=}}
| |
− | {{tp|p=32147577|t=2020. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2 |pdf=|usr=}}
| |
− | {{tp|p=32330274|t=ä. COVID-19 with spontaneous pneumothorax,pneumomediastinum and subcutaneous emphysema |pdf=|usr=}}
| |
− | {{tp|p=C7142699|t=ä. The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support |pdf=|usr=}}
| |
| | | |
− |
| |
− |
| |
− | *'''[[Case series]]'''
| |
| *'''[[Registries]]''' | | *'''[[Registries]]''' |
− | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
− |
| |
− |
| |
− | ----
| |
| | | |
| | | |
| *'''[[Trials]]''' | | *'''[[Trials]]''' |
− | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
− | ----
| |
− |
| |
− | *'''[[Remission, recurrence and persistence]]'''
| |
− | {{tp|p=32303482|t=ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case |pdf=|usr=}}
| |
− | {{tp|p=32299784|t=ä. How do we decide to de-isolate COVID-19 patients?|pdf=|usr=}}
| |
− | {{tp|p=32105304|t=2020. Positive RT-PCR Test Results in Patients Recovered From COVID-19 |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
− | {{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
− | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| + | |
− | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
− | {{tp|p=32129805|t=2020. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient |pdf=|usr=}}
| |
| | | |
− | *'''[[Running your hospital]]'''
| |
| | | |
− | ----
| + | |
| + | *'''[[Running your hospital]]''' |
| | | |
| | | |
| *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| + | |
| *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
− | {{tp|p=32259192|t=ä. US Public Concerns About the COVID-19 Pandemic From Results of a Survey Given via Social Media |pdf=|usr=}}
| |
− | {{tp|p=32329784|t=ä. Mental Health Status Among Children in Home Confinement During the Coronavirus Disease 2019 Outbreak in Hubei Province, China |pdf=|usr=}}
| |
− | {{tp|p=32338613|t=2020. COVID-19-Related Web Search Behaviors and Infodemic Attitudes in Italy: Infodemiological Study |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 167: |
Zeile 131: |
| | | |
| *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
− | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
− | *'''[[Economic aspects of the status hygienicus]]'''
| |
− | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
− | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
− | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
− | {{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
| |
| | | |
| + | |
| + | *'''[[Economic aspects of the status hygienicus]]''' |
| | | |
| | | |
Zeile 184: |
Zeile 145: |
| | | |
| *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
− | {{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
| |
− | {{tp|p=32346658|t=ä. SARS-CoV-2 and Bats: From Flight to Fighting COVID-19 |pdf=|usr=}}
| |
| | | |
| *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
− | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | |
| + | *'''[[Epidemiology]]''' |
| | | |
| | | |
− | *'''[[Epidemiology]]'''
| |
| | | |
− | *'''[[Failure of politics and public health guidance]]''' | + | |
− | {{tp|p=32240972|t=2020. The Three Steps Needed to End the COVID-19 Pandemic: Bold Public Health Leadership, Rapid Innovations, and Courageous Political Will |pdf=|usr=}}
| + | |
| + | *'''[[Remission, recurrence and persistence]]''' |
| + | |
| + | |
| | | |
| *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| ---- | | ---- |
| + | *'''[[Failure of politics and public health guidance]]''' |
| | | |
| | | |
| *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
− | {{tp|p=32309854|t=ä. World leaders? usage of Twitter in response to the COVID-19 pandemic: a content analysis |pdf=|usr=}}
| |
− | {{tp|p=32347895|t=ä. Internet Searches for Unproven COVID-19 Therapies in the United States |pdf=|usr=}}
| |
− | {{tp|p=32250960|t=2020. Misinformation of COVID-19 on the Internet: Infodemiology Study |pdf=|usr=}}
| |
− |
| |
| | | |
| | | |
| | | |
| *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
− | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
− | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
− | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
− | {{tp|p=32292846|t=2020. Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls |pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| + | |
| ---- | | ---- |
| | | |
| | | |
| *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
− | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| + | *'''[[misc.]]''' |
− | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
− | {{tp|p=32333979|t=ä. Lessons already learnt from the Covid-19 pandemic |pdf=|usr=}}
| + | |
− | {{tp|p=32305592|t=ä. Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection |pdf=|usr=}}
| + | |
− | {{tp|p=32202641|t=2020. Exercising Heart and Head in Managing Coronavirus Disease 2019 in Wuhan |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
− | *'''[[Research tools]]''' | + | |
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| + | |
| + | |
| + | *'''[[PrePrint scene]]''' |
| + | |
| | | |
| *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
− | *[lifechemicals.com antiviral candidate drugs]
| |
− | *[biomol.com assays cytokines general spectrum]
| |
− | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
− | *[codexdna.com dna synthesis]
| |
− | *
| |
| | | |
| *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| + | *'''[[on-topic personal thoughts]]''' |